India has played a significant role in supplying cost-effective generic drugs, supporting healthcare systems worldwide for a considerable amount of time. Yet, worries have arisen about the provision of healthcare in countries relying on these...
India's status as the "pharmacy of the world" is based on its ability to create drug details and nonexclusive medications. Be that as it may, this standing lays on a tricky establishment, with roughly 70% of its Dynamic Drug Fixings (APIs) obtained..
Long-term health management products, specifically chronic therapies, have been driving the growth of the Indian Pharmaceutical Market (IPM) with a 10% increase, in contrast to acute therapies which saw a 2% growth, showing a trend towards prolong...
Glenmark became the first Indian company to introduce a biosimilar of the anti-diabetic GLP-1 drug Liraglutide in India. Additionally, it has revealed a number of collaborations to introduce new drugs, such as partnerships with Jiangsu Alphamab...
The United States continues to be a crucial market for the Indian pharmaceutical industry, representing approximately 30% of overall sales and capturing a 40% share of the market in terms of volume. Despite possible risks from changes in duty...
Strengthening of Pharmaceutical Industry (SPI)' initiative, backed by Rs 500 crore (USD 60.9 million) provides vital support to enhance productivity, quality and sustainability across pharma clusters and MSMEs nationwide....
The production facility of Lubrizol in India will expand its production of medical tubing by five times, improving availability of life-saving medical tubing locally and for global markets through exports. The collaboration will result in the...
In an exclusive interview with India Pharma Outlook Magazine,Kapil Choudhury, Head of Global Business Development, Aurigene Pharmaceutical Services, shares how the Indian CRDMO leaders can equip themselves for the incoming business resulting from ...
In an exclusive interaction with India Pharma Outlook, Dr. Mahesh Bhalgat, Group CEO and MD of Veeda Clinical Research Limited discusses key trends in the CRO/CDMO industry, such as digital transformation, niche specialization, global expansion...
Venus Remedies announced that its robotic pre-filled syringe facility at the Baddi unit has been granted approval for good manufacturing practices (GMP) by the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia. Venus Remedies announced...
, CDSCO.jpg)
